Recall Register

Drug recall: Sterile Cannabidiol (CBD) 4mg/mL, 10mL vial

Class II FDA enforcement event 85706. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

BIOTA Biosciences LLC started this drug recall on 11 May 2020. The firm address in the FDA record is in Seattle, WA. FDA put the recall in Class II. FDA event 85706 has 5 product records. The first FDA enforcement report date is 1 Jul 2020. The record gives the status Terminated, with the termination date 3 Dec 2020.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide within the United States and New Zealand

Recalling firm

BIOTA Biosciences LLC, Seattle, WA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

5 product records in the event.

FDA event 85706: product records
Recall numberProductQuantityClassStatusReport date
D-1326-2020Sterile Cannabidiol (CBD) 4mg/mL, 10mL vialN/AClass IITerminated1 Jul 2020
D-1327-2020Sterile Curcumin, 4mg/mL, 10mL vialN/AClass IITerminated1 Jul 2020
D-1328-2020Sterile Cannabidiol (CBD) 50mg/mL, 10mL vialN/AClass IITerminated1 Jul 2020
D-1329-2020Sterile Cannabidiol (CBD) + Curcumin 50mg/mL, 10 mL vialN/AClass IITerminated1 Jul 2020
D-1330-2020Sterile Curcumin 50mg/mL, 10 mL vialN/AClass IITerminated1 Jul 2020

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2020
342
Share of these events in Class II
64%
Product records in this event
5
Events of the firm on the register
1

Official channels

Cite this page

Recall Register. FDA enforcement event 85706. https://recallregister.com/fda/ii/85706/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide within the United States and New Zealand
What quantity of product is in FDA event 85706?
The event has 5 product records. The first record gives this quantity: N/A
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2020 have the same class?
64% of the 342 drug events that started in 2020 are in Class II.